Abstract
This study investigated the therapeutic potential of bacterial polysaccharides by employing a model system based on enteroxigenic Escherichia coli (ETEC)-induced hemagglutination of erythrocytes. Exopolysaccharides produced by strains of Lactobacillus reuteri inhibited ETEC-induced hemagglutination of porcine erythrocytes. No effect was observed for dextran produced from Weissella cibaria and commercially available oligo- and polysaccharides.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Bacterial Agents / isolation & purification
-
Anti-Bacterial Agents / metabolism*
-
Anti-Bacterial Agents / pharmacology
-
Antibiosis*
-
Bacterial Adhesion*
-
Enterotoxigenic Escherichia coli / drug effects*
-
Enterotoxigenic Escherichia coli / pathogenicity
-
Erythrocytes / microbiology*
-
Hemagglutination / drug effects
-
Leuconostocaceae / metabolism
-
Limosilactobacillus reuteri / metabolism*
-
Polysaccharides, Bacterial / isolation & purification
-
Polysaccharides, Bacterial / metabolism*
-
Polysaccharides, Bacterial / pharmacology
-
Swine
Substances
-
Anti-Bacterial Agents
-
Polysaccharides, Bacterial